Literature DB >> 23822743

Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease.

P Cheng1, W Shih, M Alberto, A P Presson, A Licudine, E A Mayer, B D Naliboff, L Chang.   

Abstract

BACKGROUND: Previous studies reported altered autonomic nervous system (ANS) responses in irritable bowel syndrome (IBS) at baseline and to colonic balloon distension. This study examined heart rate variability (HRV) and plasma catecholamines as an index of ANS responsiveness in IBS during flexible sigmoidoscopy (FS) and explored associations of HRV with clinical measures.
METHODS: Rome III-positive IBS patients and healthy controls completed questionnaires measuring gastrointestinal and psychological symptoms. Heart rate variability measures were calculated using electrocardiogram (ECG) data at rest and during FS. Plasma catecholamines were measured before and after the FS. Linear mixed effects models were used to compare HRV with IBS status and IBS duration across six time points. Significance was assessed at the 0.05 level. KEY
RESULTS: Thirty-six IBS patients (53% F, mean age 37.89) and 31 controls (58% F, mean age 37.26) participated. After adjusting for age, sex, body mass index, and current anxiety symptoms, IBS patients had a non-significant lower cardiovagal tone (P = 0.436) and higher cardiosympathetic balance (P = 0.316) at rest. During FS, controls showed a transient increase in cardiosympathetic balance and decrease in cardiovagal tone. However, IBS patients had significantly less cardiosympathetic and cardiovagal responsiveness both leading up to (P = 0.003, P = 0.005) and following (P = 0.001) this stimulus. Those with longer duration of disease had less cardiosympathetic (P = 0.014) and cardiovagal (P = 0.009) responsiveness than those with shorter duration. No differences in catecholamines between IBS and controls were found. CONCLUSIONS & INFERENCES: Irritable bowel syndrome demonstrated dysregulated ANS responses to a visceral stressor which could be related to disease duration. Therefore, autonomic dysregulation is an objective physiologic correlate of IBS.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  autonomic dysregulation; autonomic nervous system; blunting; duration of disease; heart rate variability; irritable bowel syndrome; physiologic correlate; plasma catecholamines; somatic stressor; visceral stressor

Mesh:

Substances:

Year:  2013        PMID: 23822743      PMCID: PMC3788031          DOI: 10.1111/nmo.12177

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  46 in total

Review 1.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 2.  Heart rate variability: origins, methods, and interpretive caveats.

Authors:  G G Berntson; J T Bigger; D L Eckberg; P Grossman; P G Kaufmann; M Malik; H N Nagaraja; S W Porges; J P Saul; P H Stone; M W van der Molen
Journal:  Psychophysiology       Date:  1997-11       Impact factor: 4.016

3.  Different autonomic responses to experimental pain in IBS patients and healthy controls.

Authors:  Yannick Tousignant-Laflamme; Philippe Goffaux; Patricia Bourgault; Serge Marchand
Journal:  J Clin Gastroenterol       Date:  2006-10       Impact factor: 3.062

4.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

Review 5.  Functional bowel disorders.

Authors:  George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome.

Authors:  J Munakata; B Naliboff; F Harraf; A Kodner; T Lembo; L Chang; D H Silverman; E A Mayer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Perception of electrocutaneous stimuli in irritable bowel syndrome.

Authors:  Paola Iovino; Fabrizio Tremolaterra; Danilo Consalvo; Francesco Sabbatini; Gabriele Mazzacca; Carolina Ciacci
Journal:  Am J Gastroenterol       Date:  2006-02-08       Impact factor: 10.864

9.  Subtle involvement of the parasympathetic nervous system in patients with irritable bowel syndrome.

Authors:  Narender P van Orshoven; Gunnar I Andriesse; Leonard J van Schelven; André J Smout; Louis M A Akkermans; P Liam Oey
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

Review 10.  Protective and damaging effects of stress mediators: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more
  15 in total

1.  IBS: Autonomic dysregulation in IBS.

Authors:  Shin Fukudo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-03       Impact factor: 46.802

2.  Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients.

Authors:  Liang Liu; Bei-ni Liu; Shuo Chen; Miao Wang; Yang Liu; Yan-li Zhang; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

Review 3.  Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.

Authors:  Susan Lucak; Lin Chang; Albena Halpert; Lucinda A Harris
Journal:  Therap Adv Gastroenterol       Date:  2016-09-16       Impact factor: 4.409

Review 4.  Aspects of the non-pharmacological treatment of irritable bowel syndrome.

Authors:  Elsa Maria Eriksson; Kristina Ingrid Andrén; Göran Karl Kurlberg; Henry Ture Eriksson
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 5.  Sex hormones in the modulation of irritable bowel syndrome.

Authors:  Agata Mulak; Yvette Taché; Muriel Larauche
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 6.  Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms.

Authors:  Michael Camilleri
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

7.  Baroreflex mechanisms in Irritable Bowel Syndrome: Part I. Traditional indices.

Authors:  Dmitry M Davydov; Bruce Naliboff; Leila Shahabi; David Shapiro
Journal:  Physiol Behav       Date:  2016-02-02

8.  Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.

Authors:  Ferdinando Bonfiglio; Tenghao Zheng; Koldo Garcia-Etxebarria; Fatemeh Hadizadeh; Luis Bujanda; Francesca Bresso; Lars Agreus; Anna Andreasson; Aldona Dlugosz; Greger Lindberg; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Magnus Simren; Susanna Walter; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Anna Latiano; Matthias Hübenthal; Vincent Thijs; Mihai G Netea; Daisy Jonkers; Lin Chang; Emeran A Mayer; Mira M Wouters; Guy Boeckxstaens; Michael Camilleri; Andre Franke; Alexandra Zhernakova; Mauro D'Amato
Journal:  Gastroenterology       Date:  2018-04-05       Impact factor: 22.682

Review 9.  Communication between the gut microbiota and peripheral nervous system in health and chronic disease.

Authors:  Tyler M Cook; Virginie Mansuy-Aubert
Journal:  Gut Microbes       Date:  2022 Jan-Dec

10.  Catecholaminergic Gene Polymorphisms Are Associated with GI Symptoms and Morphological Brain Changes in Irritable Bowel Syndrome.

Authors:  Alexa Orand; Arpana Gupta; Wendy Shih; Angela P Presson; Christian Hammer; Beate Niesler; Nuwanthi Heendeniya; Emeran A Mayer; Lin Chang
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.